XML 55 R44.htm IDEA: XBRL DOCUMENT
v3.22.1

Long-Term Investments (Details) - shares | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2022 | Dec. 31, 2021
BioFirst [Member] |  |
Long-Term Investments (Details) [Line Items] |  |
Percentage of common stock shares | 15.99% | 15.99%
Additional shares issued (in Shares) | 663,798 | 684,720
Rgene [Member] |  |
Long-Term Investments (Details) [Line Items] |  |
Percentage of common stock shares | 31.62% | 31.62%

X
- References No definition available. + Details
Name: | abvc_LongTermInvestmentsDetailsLineItems
Namespace Prefix: | abvc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of excess stock shares of an entity that have been sold or granted to shareholders. + References No definition available. + Details
Name: | us-gaap_ExcessStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioFirstCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_RgeneCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |